Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
776.87B | 824.77B | 727.40B | 552.18B | 526.00B | Gross Profit |
363.08B | 421.16B | 363.85B | 265.85B | 259.85B | EBIT |
196.23B | 258.20B | 227.86B | 153.35B | 146.25B | EBITDA |
286.09B | 283.97B | 248.42B | 171.94B | 162.92B | Net Income Common Stockholders |
178.32B | 224.61B | 192.99B | 121.79B | 110.50B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
511.29B | 623.50B | 697.05B | 640.55B | 560.76B | Total Assets |
2.09T | 1.93T | 1.77T | 1.54T | 1.39T | Total Debt |
13.07B | 12.19B | 11.54B | 10.79B | 11.52B | Net Debt |
-498.19B | -591.38B | -673.29B | -618.50B | -536.79B | Total Liabilities |
208.69B | 225.62B | 210.68B | 159.88B | 137.27B | Stockholders Equity |
1.88T | 1.70T | 1.56T | 1.38T | 1.25T |
Cash Flow | Free Cash Flow | |||
-6.10B | 27.24B | 75.16B | 91.18B | 85.63B | Operating Cash Flow |
98.21B | 101.62B | 156.09B | 120.47B | 124.61B | Investing Cash Flow |
-131.90B | -87.09B | -116.22B | 73.44B | 24.92B | Financing Cash Flow |
-87.93B | -113.30B | -88.93B | -56.01B | -49.92B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | $15.35B | 24.06 | 18.59% | 1.03% | -0.42% | 3.23% | |
75 Outperform | $13.71B | 28.74 | 12.73% | 1.52% | 1.66% | -17.18% | |
71 Outperform | $10.97B | 24.56 | 16.15% | 1.57% | 0.78% | -8.42% | |
69 Neutral | $30.93B | 37.93 | 8.09% | 0.10% | 5.27% | 0.61% | |
67 Neutral | $28.68B | 31.56 | 26.22% | 2.02% | -11.28% | -23.69% | |
64 Neutral | $4.27B | 11.80 | 5.31% | 249.79% | 4.07% | -9.02% | |
60 Neutral | $21.56B | 19.68 | 8.42% | 1.40% | -6.85% | -20.37% |